We are live on ! Find out more
PAM

Palisade Asset Management Portfolio holdings

AUM $1.08B
1-Year Est. Return 22.62%
This Fund
S&P 500
This Quarter Est. Return
-2.55%
1 Year Est. Return
+22.62%
3 Year Est. Return
+61.8%
5 Year Est. Return
+76.07%
10 Year Est. Return
+251.97%
AUM
$986M
AUM Growth
-$35.7M
Cap. Flow
-$1.76M
Cap. Flow %
-0.18%
Top 10 Hldgs %
33.07%
Holding
199
New
2
Increased
47
Reduced
88
Closed
6

Top Buys

Rank Stock Value
1
HSY icon
Hershey
HSY
+$2.76M
2
UNH icon
UnitedHealth
UNH
+$814K
3
MRK icon
Merck
MRK
+$583K
4
AMGN icon
Amgen
AMGN
+$374K
5
ABT icon
Abbott
ABT
+$357K

Top Sells

Rank Stock Value
1
CHRW icon
C.H. Robinson
CHRW
+$1.73M
2
INTC icon
Intel
INTC
+$861K
3
T icon
AT&T
T
+$529K
4
HRL icon
Hormel Foods
HRL
+$444K
5
BLK icon
Blackrock
BLK
+$439K

Sector Composition

Rank Sector Weight
1 Technology 25.64%
2 Healthcare 17.68%
3 Consumer Staples 10.7%
4 Financials 10.6%
5 Industrials 10%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSFT icon
1
Microsoft
MSFT
$2.85T
$60M 6.08%
142,234
-412
-0.3% -$175K
AAPL icon
2
Apple
AAPL
$4.89T
$58.2M 5.9%
232,223
-1,810
-0.8% -$427K
UNH icon
3
UnitedHealth
UNH
$382B
$33.7M 3.42%
66,685
+1,432
+2% +$814K
ORCL icon
4
Oracle
ORCL
$333B
$31.2M 3.17%
187,473
-2,047
-1% -$364K
HD icon
5
Home Depot
HD
$331B
$27.1M 2.75%
69,650
-652
-0.9% -$266K
ABT icon
6
Abbott
ABT
$180B
$27M 2.74%
238,587
+3,086
+1% +$357K
SPY icon
7
State Street SPDR S&P 500 ETF Trust
SPY
$777B
$23.8M 2.42%
40,664
-223
-0.5% -$131K
IBM icon
8
IBM
IBM
$203B
$22.7M 2.3%
103,138
-317
-0.3% -$70.6K
CSCO icon
9
Cisco
CSCO
$450B
$21.8M 2.21%
368,501
-1,339
-0.4% -$76.5K
TGT icon
10
Target
TGT
$62.3B
$20.4M 2.07%
150,988
+1,661
+1% +$238K
PG icon
11
Procter & Gamble
PG
$342B
$19.8M 2.01%
118,046
-311
-0.3% -$53K
JPM icon
12
JPMorgan Chase
JPM
$937B
$19.4M 1.97%
80,923
-308
-0.4% -$71.7K
AMGN icon
13
Amgen
AMGN
$203B
$19.1M 1.94%
73,210
+1,262
+2% +$374K
ADP icon
14
Automatic Data Processing
ADP
$100B
$18.2M 1.85%
62,274
-367
-0.6% -$108K
ECL icon
15
Ecolab
ECL
$75.5B
$17.9M 1.81%
76,252
-512
-0.7% -$127K
DE icon
16
Deere & Co
DE
$169B
$16.2M 1.65%
38,347
-192
-0.5% -$80.9K
ABBV icon
17
AbbVie
ABBV
$458B
$15.8M 1.6%
88,753
-1,215
-1% -$223K
JNJ icon
18
Johnson & Johnson
JNJ
$634B
$15.2M 1.54%
105,011
+185
+0.2% +$28.7K
MCD icon
19
McDonald's
MCD
$188B
$15.1M 1.53%
52,013
-142
-0.3% -$42.3K
PEP icon
20
PepsiCo
PEP
$187B
$15M 1.52%
98,761
+623
+0.6% +$102K
LLY icon
21
Eli Lilly
LLY
$1.06T
$14.7M 1.49%
19,058
-12
-0.1% -$9.94K
V icon
22
Visa
V
$674B
$14.3M 1.45%
45,231
-431
-0.9% -$130K
CVX icon
23
Chevron
CVX
$388B
$14.1M 1.43%
97,091
+1,703
+2% +$261K
SYK icon
24
Stryker
SYK
$126B
$13.8M 1.4%
38,206
-107
-0.3% -$39.6K
BLK icon
25
Blackrock
BLK
$164B
$13.3M 1.35%
12,934
-433
-3% -$439K

Similar funds

Palisade Asset Management's Q4 2024 Portfolio in Review

As of Q4 2024, Palisade Asset Management held 199 positions worth $986M, down 3.5% from $1.02B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Trading was light in Q4 2024: portfolio turnover was 4%. Palisade Asset Management opened 2 new positions and exited 6, leaving the 199-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Palisade Asset Management's largest Q4 2024 buy was Everus Construction Group: 4,673 shares worth $307K.
  • Palisade Asset Management added most to Hershey in Q4 2024, an estimated $2.76M increase.
  • Palisade Asset Management's biggest Q4 2024 reduction was C.H. Robinson, cutting an estimated $1.73M.
  • Palisade Asset Management fully exited Baxter International in Q4 2024, selling an estimated $326K.
  • Palisade Asset Management's ten largest holdings make up 33% of its $986M portfolio in Q4 2024.
  • Palisade Asset Management opened 2 new positions and closed 6 in Q4 2024.
  • Palisade Asset Management's portfolio value fell 3.5% quarter-over-quarter to $986M.

Based on Palisade Asset Management's 13F filing for Q4 2024, filed 11 Feb 2025.